Security key
89357L204
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 593,403
- Total 13F value
- $97,148
- Share change
- +33,344
- SEC-reported price per share
- $0.16
- Number of holders
- 11
- Value change
- -$127,458
- Number of buys
- 9
- Number of sells
- 6
Report period
Q4 2023
Institutions
11
Top holders
10
RNAZ full security history
Ownership snapshot
Full 13F holder table
Transcode Therapeutics, Inc. SEC filings
Transcode Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of RNAZ - TRANSCODE THERAPEUTICS INC - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Anna Moore
Disclosed value leader
Anna Moore
Comparable rows
0/13
Latest evidence
30 Sep 2023
3/4/5
13F
Highest disclosed value: $791,920
13 rows are not safely comparable across share classes.
Showing 1-6 of 13 holder rows.
Quick read
Anna Moore has the largest disclosed position value at $791.9K.
0 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Anna Moore's linked filing trail.
Disclosed position value
Top 5
Anna Moore
$791.9K
SABBY MANAGEMENT, LLC
$125.8K
Robert Michael Dudley
$91.9K
UBS Group AG
$73.7K
TANG CAPITAL MANAGEMENT LLC
$42.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Anna Moore |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$791,920
1,552,785 shares
|
— | 08 Jul 2021 |
| Zdravka Medarova |
3/4/5
Chief Technology Officer, 10%+ Owner
|
—
denominator unverified
|
—
60,000 shares
|
— | 12 Dec 2022 |
| SABBY MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$125,830
250,309 shares
|
— | 30 Sep 2023 |
| Robert Michael Dudley |
3/4/5
Chief Executive Officer, Director
|
—
denominator unverified
|
$91,934
180,262 shares
|
— | 28 Sep 2023 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$73,705
146,530 shares
|
— | 30 Sep 2023 |
| TANG CAPITAL MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$42,232
84,010 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
593,403
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
10
Q4 2023 holders
11
Holder diff
1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|